Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-12

Clinical Trial Update: Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation [Phase 3]

View source ↗

Summary

Ongoing Phase III clinical study of a polyherbal anti-diabetic formulation for type 2 diabetes mellitus; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Poly Herbal Anti-Diabetic Formulation

Snippet

Sponsor: Hamdard University | Conditions: Diabetes Type 2, Diabetes Mellitus, Experimental | Phase 3 | Status: ACTIVE_NOT_RECRUITING